Literature DB >> 15357994

Possible differences in modes of agonist and antagonist binding at human 5-HT6 receptors.

Manik R Pullagurla1, Richard B Westkaemper, Richard A Glennon.   

Abstract

A graphics model of the human 5-HT6 receptor was constructed and automated docking studies were performed. The model suggests that 5-HT6 antagonist arylsulfonyltryptamines might bind differently than that of the agonist serotonin. Furthermore, the model explains many of the empirical results from our previous structure-affinity studies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15357994     DOI: 10.1016/j.bmcl.2004.05.076

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

Review 1.  Role of serotonin in Alzheimer's disease: a new therapeutic target?

Authors:  Werner J Geldenhuys; Cornelis J Van der Schyf
Journal:  CNS Drugs       Date:  2011-09-01       Impact factor: 5.749

2.  In Silico Screening of Natural Compounds for Candidates 5HT6 Receptor Antagonists against Alzheimer's Disease.

Authors:  Tijana Bojić; Milan Sencanski; Vladimir Perovic; Jelena Milicevic; Sanja Glisic
Journal:  Molecules       Date:  2022-04-19       Impact factor: 4.927

3.  Binding of serotonin and N1-benzenesulfonyltryptamine-related analogs at human 5-HT6 serotonin receptors: receptor modeling studies.

Authors:  Małgorzata Dukat; Philip D Mosier; Renata Kolanos; Bryan L Roth; Richard A Glennon
Journal:  J Med Chem       Date:  2008-01-18       Impact factor: 7.446

4.  Investigation of the structure requirement for 5-HT₆ binding affinity of arylsulfonyl derivatives: a computational study.

Authors:  Ming Hao; Yan Li; Hanqing Li; Shuwei Zhang
Journal:  Int J Mol Sci       Date:  2011-08-08       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.